← Back to Screener
Establishment Labs Holdings Inc. (ESTA)
Price$66.93
Favorite Metrics
Price vs S&P 500 (26W)63.52%
Price vs S&P 500 (4W)-2.42%
Market Capitalization$1.96B
All Metrics
Book Value / Share (Quarterly)$0.80
P/TBV (Annual)155.66x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)9.29%
Cash Flow / Share (Quarterly)$-1.97
Price vs S&P 500 (YTD)-12.10%
Gross Margin (TTM)69.32%
Net Profit Margin (TTM)-24.19%
EPS (TTM)$-1.74
10-Day Avg Trading Volume0.44M
EPS Excl Extra (TTM)$-1.74
Revenue Growth (5Y)20.04%
EPS (Annual)$-1.72
ROI (Annual)-18.01%
Gross Margin (Annual)69.32%
Net Profit Margin (5Y Avg)-40.32%
Cash / Share (Quarterly)$2.58
Revenue Growth QoQ (YoY)45.16%
ROA (Last FY)-14.30%
Revenue Growth TTM (YoY)27.14%
EBITD / Share (TTM)$-1.02
ROE (5Y Avg)-186.96%
Operating Margin (TTM)-18.48%
Cash Flow / Share (Annual)$-1.97
P/B Ratio83.34x
P/B Ratio (Quarterly)89.94x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)10.11x
Net Interest Coverage (TTM)-2.15x
ROA (TTM)-15.03%
EPS Incl Extra (Annual)$-1.72
Current Ratio (Annual)3.04x
Quick Ratio (Quarterly)1.91x
3-Month Avg Trading Volume0.50M
52-Week Price Return122.27%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.46
P/S Ratio (Annual)9.30x
Asset Turnover (Annual)0.59x
52-Week High$83.31
Operating Margin (5Y Avg)-28.81%
EPS Excl Extra (Annual)$-1.72
CapEx CAGR (5Y)11.44%
Tangible BV CAGR (5Y)-17.78%
26-Week Price Return72.27%
Quick Ratio (Annual)1.91x
13-Week Price Return1.34%
Total Debt / Equity (Annual)11.04x
Current Ratio (Quarterly)3.04x
Enterprise Value$2,134.394
Revenue / Share Growth (5Y)14.41%
Asset Turnover (TTM)0.62x
Book Value / Share Growth (5Y)-16.01%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)0.79x
Pretax Margin (Annual)-27.49%
Cash / Share (Annual)$2.58
3-Month Return Std Dev49.43%
Gross Margin (5Y Avg)66.68%
Net Income / Employee (TTM)$-0
ROE (Last FY)-216.86%
Net Interest Coverage (Annual)-2.15x
EPS Basic Excl Extra (Annual)$-1.72
Receivables Turnover (TTM)2.96x
Total Debt / Equity (Quarterly)10.51x
EPS Incl Extra (TTM)$-1.74
Receivables Turnover (Annual)2.96x
ROI (TTM)-19.70%
P/S Ratio (TTM)9.30x
Pretax Margin (5Y Avg)-40.48%
Revenue / Share (Annual)$7.13
Tangible BV / Share (Annual)$0.46
Price vs S&P 500 (52W)87.17%
Year-to-Date Return-7.96%
5-Day Price Return6.61%
EPS Normalized (Annual)$-1.72
ROA (5Y Avg)-26.60%
Net Profit Margin (Annual)-24.19%
Month-to-Date Return18.14%
Cash Flow / Share (TTM)$-2.69
EBITD / Share (Annual)$-1.01
Operating Margin (Annual)-18.48%
LT Debt / Equity (Annual)10.51x
ROI (5Y Avg)-31.49%
LT Debt / Equity (Quarterly)10.51x
EPS Basic Excl Extra (TTM)$-1.74
P/TBV (Quarterly)155.66x
P/B Ratio (Annual)89.94x
Inventory Turnover (TTM)0.79x
Pretax Margin (TTM)-27.49%
Book Value / Share (Annual)$0.80
Price vs S&P 500 (13W)-1.52%
Beta1.12x
Revenue / Share (TTM)$7.08
ROE (TTM)-201.79%
52-Week Low$28.67
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.20
4.14
4.20
4.20
Industry Peers — Orthopedic & Prosthetic Devices(25)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
ESTAEstablishment Labs Holdings Inc. | 9.30x | 20.04% | 69.32% | -18.48% | $66.93 |
ISRGIntuitive Surgical Inc. | 16.54x | 18.22% | 66.00% | 29.27% | $465.60 |
EWEdwards Lifesciences Corp | 7.77x | 6.70% | 78.01% | 18.41% | $81.44 |
STESTERIS plc | 3.81x | 12.49% | 44.11% | 17.03% | $226.41 |
ZBHZimmer Biomet Holdings, Inc. | 2.31x | 3.22% | 69.71% | 13.34% | $95.48 |
ALGNAlign Technology Inc | 3.41x | 10.30% | 68.27% | 13.53% | $191.66 |
SNNSmith & Nephew plc | 2.37x | 6.21% | 68.01% | 12.88% | $34.21 |
MSAMine Safety Incorporated | 3.60x | 6.82% | 46.46% | 19.83% | $173.50 |
ENOVEnovis Corporation | 0.68x | -6.05% | 58.16% | -50.09% | $26.27 |
CDRECadre Holdings, Inc. | 2.19x | 8.57% | 42.54% | 11.04% | $30.51 |
AVNSAvanos Medical, Inc. | 1.64x | -0.38% | 50.47% | -8.78% | $24.64 |
About
Establishment Labs Holdings Inc. is a medical technology company specializing in the design, manufacture, and distribution of silicone-filled breast and body-shaping implants under the Motiva brand. The company distributes its aesthetic medical devices through direct sales channels to physicians, hospitals, clinics, and medical distributors across Europe, Latin America, Asia-Pacific, the Middle East, and other regions.